Mathilde Sibony

9.2k total citations · 1 hit paper
128 papers, 4.4k citations indexed

About

Mathilde Sibony is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mathilde Sibony has authored 128 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 44 papers in Molecular Biology and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mathilde Sibony's work include Bladder and Urothelial Cancer Treatments (32 papers), Renal cell carcinoma treatment (26 papers) and Renal and related cancers (22 papers). Mathilde Sibony is often cited by papers focused on Bladder and Urothelial Cancer Treatments (32 papers), Renal cell carcinoma treatment (26 papers) and Renal and related cancers (22 papers). Mathilde Sibony collaborates with scholars based in France, United Kingdom and United States. Mathilde Sibony's co-authors include Pierre Corvol, Jean‐Marie Gasc, Olivier Cussenot, Annick Vieillefond, Vincent Molinié, Yves Allory, Freddie C. Hamdy, James W.F. Catto, Ishtiaq Rehman and P Callard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mathilde Sibony

116 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-converting enzyme and male fertility

1998 280 citations Mathilde Sibony et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathilde Sibony France	33	2.0k	1.4k	1.4k	911	735	128	4.4k
Toshiyuki Nakayama Japan	35	1.6k 0.8×	1.0k 0.7×	1.0k 0.7×	649 0.7×	1.4k 1.9×	171	4.2k
Hiroshi Kanetake Japan	34	2.0k 1.0×	959 0.7×	1.1k 0.8×	796 0.9×	899 1.2×	210	4.1k
W. Böcker Germany	38	1.8k 0.9×	918 0.6×	576 0.4×	890 1.0×	1.3k 1.8×	183	4.7k
Shuji Mikami Japan	36	1.7k 0.8×	1.3k 0.9×	1.5k 1.1×	611 0.7×	955 1.3×	206	4.1k
Peter Oettgen United States	46	3.3k 1.6×	738 0.5×	519 0.4×	1.1k 1.3×	953 1.3×	85	5.8k
Catherine Limas United States	25	2.0k 1.0×	862 0.6×	2.1k 1.5×	784 0.9×	690 0.9×	56	4.0k
Kalle Alanen Finland	34	1.5k 0.7×	530 0.4×	942 0.7×	754 0.8×	1.5k 2.1×	98	3.8k
Manuel R. Teixeira Portugal	43	3.4k 1.7×	640 0.5×	1.9k 1.3×	1.9k 2.1×	1.7k 2.3×	225	6.4k
Mark Southwood United Kingdom	33	1.3k 0.7×	618 0.4×	2.7k 1.9×	727 0.8×	272 0.4×	72	4.2k
Janusz Ryś Poland	30	1.0k 0.5×	835 0.6×	1.5k 1.1×	809 0.9×	1.3k 1.8×	170	4.0k

Countries citing papers authored by Mathilde Sibony

Since Specialization

Citations

This map shows the geographic impact of Mathilde Sibony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Sibony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Sibony more than expected).

Fields of papers citing papers by Mathilde Sibony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Sibony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Sibony. The network helps show where Mathilde Sibony may publish in the future.

Co-authorship network of co-authors of Mathilde Sibony

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Sibony. A scholar is included among the top collaborators of Mathilde Sibony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Sibony. Mathilde Sibony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jouinot, Anne, Nadim Hamzaoui, Olivier Huillard, et al.. (2025). Predisposition to prostate cancer and clinical implications in a real-life cohort. European Journal of Human Genetics. 33(9). 1163–1172.

Bouys, Lucas, et al.. (2024). Bilateral Adrenocortical Nodular Disease and Cushing's Syndrome. The Journal of Clinical Endocrinology & Metabolism. 109(10). 2422–2432. 6 indexed citations

Jouinot, Anne, Lucas Bouys, Stéphanie Espiard, et al.. (2024). Carney complex predisposes to breast cancer: prospective study of 50 women. European Journal of Endocrinology. 190(2). 121–129.

Timsit, Marc‐Olivier, Mathilde Sibony, Viorel Vasiliu, et al.. (2021). Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1. Modern Pathology. 35(3). 352–360. 37 indexed citations

Kantari‐Mimoun, Chahrazade, Sarah Barrin, Lene Vimeux, et al.. (2021). CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1. Cancer Immunology Research. 9(12). 1425–1438. 51 indexed citations

Kossaï, Myriam, C. Radulescu, Julien Adam, et al.. (2021). Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC. Urologic Oncology Seminars and Original Investigations. 40(1). 12.e1–12.e11. 9 indexed citations

Denize, Thomas, Mathilde Sibony, Hélène Blons, et al.. (2020). MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features. Modern Pathology. 34(3). 647–659. 18 indexed citations

Job, Sylvie, Irena Drašković, Nelly Burnichon, et al.. (2018). Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma. Clinical Cancer Research. 25(2). 760–770. 83 indexed citations

Garinet, Simon, G. Pignot, Sophie Vacher, et al.. (2018). High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer. Molecular Cancer Research. 17(2). 469–475. 18 indexed citations

10.

Nguyen, Tuan Thanh, Olivier Huillard, Yohann Dabi, et al.. (2018). Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience. Frontiers in Surgery. 5. 58–58. 16 indexed citations

11.

Granier, Clémence, Charles Dariane, Pierre Combe, et al.. (2016). Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma. Cancer Research. 77(5). 1075–1082. 163 indexed citations

12.

Dabi, Yohann, J. Anract, Nicolas Barry Delongchamps, et al.. (2016). Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer. World Journal of Urology. 35(2). 229–235. 25 indexed citations

13.

Beuselinck, Benoit, Sylvie Job, Étienne Becht, et al.. (2015). Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting. Clinical Cancer Research. 21(6). 1329–1339. 230 indexed citations

14.

Trpkov, Kiril, Ondřej Hes, Michael Bonert, et al.. (2015). Eosinophilic, Solid, and Cystic Renal Cell Carcinoma. The American Journal of Surgical Pathology. 40(1). 60–71. 132 indexed citations

15.

Albigès, Laurence, Justine Guégan, Audrey Le Formal, et al.. (2014). MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array. Clinical Cancer Research. 20(13). 3411–3421. 134 indexed citations

16.

Rebouissou, Sandra, Aurélie Hérault, Éric Letouzé, et al.. (2012). CDKN2A homozygous deletion is associated with muscle invasion in FGFR3 ‐mutated urothelial bladder carcinoma. The Journal of Pathology. 227(3). 315–324. 77 indexed citations

17.

Frapsauce, Cynthia, Célia Ravel, Marie Legendre, et al.. (2011). Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation. Human Reproduction. 26(3). 724–728. 32 indexed citations

18.

Molinié, Vincent, Mathilde Sibony, Gaëlle Fromont, et al.. (2008). Fiche compte rendu standardisé et biopsies prostatiques.. Annales de Pathologie. 28(5).

19.

Allory, Yves, Céline Bazille, Annick Vieillefond, et al.. (2007). Profiling and classification tree applied to renal epithelial tumours. Histopathology. 52(2). 158–166. 54 indexed citations

20.

Catto, James W.F., Abdel-Rahmène Azzouzi, Najla Amira, et al.. (2003). Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene. 22(54). 8699–8706. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact